ImmuPharma PLC (LSE:IMM) - Share price - Overview

Stock Report

ImmuPharma PLC IMM

Last Price
GBX55.75

Day Change
-1.75|-3.04%

As of 26/07/2017
16:55:40 BST | GBX
Minimum 15 Minutes Delay.

Last Close57.50p
Day Range55.75 - 57.65
Mkt Cap76.20Mil
52-Wk Range31.44 - 70.32
Yield %0.00
ISINGB0033711010
Volume165,682
P/E-12.28
P/S395.39
P/CF-10.09

Share Price

Total Returns 25/07/2017

 Chg (%)  
More ...
ImmuPharma PLC9.79 
FTSE 100 TR GBP0.19
 
Financials
201420152016
More ...
Income Statement
Turnover0.190.080.17
Operating Profit-3.43-4.56-6.59
Net Profit-2.87-3.90-5.32
Reported EPS-3.43-4.40-4.54
Balance Sheet
Current Assets6.152.415.97
Non Current Assets0.930.800.74
Total Assets7.073.216.71
Current Liabilities0.991.240.95
Total Liabilities1.371.521.16
Total Equity5.711.695.55
Cash Flow
Operating Cash Flow-3.23-4.58-7.19
Net Change in Cash0.20-4.470.90
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

ImmuPharma PLC is a drug discovery and development company. The Company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.

Sector

Biotechnology

Market Position

985 of 1846 Companies

Index

FTSE AIM All Share

Outlook

(07/06/2017) no outlook statement

Next Event 02/10/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0014.6216.37
Div Yld (E)0.003.784.10
PEG (E)0.000.510.95
ROCE-116.95190.1112.97
Op Mrgn-3,826.67-5.203.67
EPS Grwth0.0035.4829.46
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanTim McCarthy
Chief Executive OfficerMr. Dimitri Dimitriou
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.